Oral mucositis associated with anti-egfr therapy in colorectal cancer: single institutional retrospective cohort study.

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-PPR-004
• By: DOTE, Satoshi (Kyoto-Katsura Hospital, Department of pharamcy, Kyoto, Japan)
• Co-author(s): Satoshi Dote: Department of pharamcy, Kyoto-Katsura Hospital, Kyoto, Japan;Department of pharamcy, Shiga University of Medical Science Hospital, Shiga, Japan
  Shoji Itakura: Department of pharamcy, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan
  Daiki Hira: Department of pharamcy, Shiga University of Medical Science Hospital, Shiga, Japan
  Satoshi Noda: Department of pharamcy, Shiga University of Medical Science Hospital, Shiga, Japan
  Yuka Kobayashi: Department of pharamcy, Kyoto-Katsura Hospital, Kyoto, Japan
  Tomohiro Terada: Department of pharamcy, Shiga University of Medical Science Hospital, Shiga, Japan
  
• Abstract:

  Background

  The difference of severity of oral mucositis between anti-EGFR therapies combined with cytotoxics in colorectal cancer are not clear.

  Purpose

  The aim of this study was to investigate the differences of oral mucositis between panitumumab (Pmab) and cetuximab (Cmab) combined with 5FU.

  Methods

  We conducted a retrospective cohort study. A total ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login